Key facts
- It has raised $215.0M across 1 recorded rounds; the latest was Early Stage VC (Series B) ($215.0M) in Nov 2024.
- 3 institutional filers report fund marks on Metsera across 11 filings.
- Metsera has filed 1 Form D with the SEC, most recently Nov 2024 ($215.0M sold to 38 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Metsera
Create free account
No card required
Funding rounds
1 roundsNov 2024Early Stage VC (Series B)$215.0M▮
About Metsera
- Industry
- Drug Discovery
PA Mark — not yet priced
Metsera doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Metsera shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
3 filers · latest Aug 20253 SEC-registered funds reported 11 fair-value marks on Metsera between Apr 2025 and Aug 2025. Filer-level marks and implied $/share are available to Pro members.